ترجمه مقاله نقش ضروری ارتباطات 6G با چشم انداز صنعت 4.0
- مبلغ: ۸۶,۰۰۰ تومان
ترجمه مقاله پایداری توسعه شهری، تعدیل ساختار صنعتی و کارایی کاربری زمین
- مبلغ: ۹۱,۰۰۰ تومان
ABSTRACT
Neuroinflammation remains a central piece in Parkinson's disease (PD) pathophysiology. However, mechanisms by which PD links to the neuroinflammation remain elusive. Here, for the first time, we report that lower dose of niacin in PD patients may affect macrophage polarization from M1 (pro-inflammatory) to M2 (counter-inflammatory) profile through the niacin receptor GPR109A. Skew in the peripheral macrophages were accompanied by improved quality of life assessments in patients. Low dose niacin supplementation may be beneficial in PD, boosting anti-inflammatory processes and suppressing inflammation. Varied niacin dosages for longer durations may further reveal the potential role of anti-inflammatory interventions in PD progression.
Conclusion
Despite all controversies about the role and impact of niacin on different diseases, our findings for the first time provides the rationale for further investigations to help better understand and define the potential therapeutic role of niacin in the treatment of PD patients. The interaction between niacin and macrophages as an important cellular component of innate immunity provides a solid base from which the potential of niacin as safe and non-expensive immunotherapeutic target may be further explored. These results may have implications for an immunotherapeutic approach to treat PD patients by niacin supplementation targeting macrophages as crucial component of immune system.